<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PONE-RA-06392R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0003565</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Hematology</subject><subject>Hematology/Bone Marrow and Stem Cell Transplantation</subject><subject>Hematology/Hematopoiesis</subject></subj-group></article-categories><title-group><article-title>SH<sub>2</sub>-Inositol Phosphatase 1 Negatively Influences Early Megakaryocyte Progenitors</article-title><alt-title alt-title-type="running-head">SHIP-Deficient Thrombopoiesis</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Perez</surname><given-names>Lia E.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Desponts</surname><given-names>Caroline</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Parquet</surname><given-names>Nancy</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kerr</surname><given-names>William G.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Immunology Program, H. Lee Moffitt Comprehensive Cancer Center and Research Institute, Tampa, Florida, United States of America</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Blood and Marrow Transplantation Program, H. Lee Moffitt Comprehensive Cancer Center and Research Institute, Tampa, Florida, United States of America</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Department of Chemistry, The Scripps Research Institute, San Diego, California, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Bauer</surname><given-names>Joseph Alan</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Cleveland Clinic, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>William.Kerr@moffitt.org</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: LEP CD WGK. Performed the experiments: CD NP. Analyzed the data: LEP CD NP WGK. Contributed reagents/materials/analysis tools: LEP WGK. Wrote the paper: LEP CD NP WGK.</p></fn></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>29</day><month>10</month><year>2008</year></pub-date><volume>3</volume><issue>10</issue><elocation-id>e3565</elocation-id><history><date date-type="received"><day>15</day><month>9</month><year>2008</year></date><date date-type="accepted"><day>8</day><month>10</month><year>2008</year></date></history><copyright-statement>Perez et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2008</copyright-year><abstract><sec><title>Background</title><p>The SH2-containing-5&#x02032;inositol phosphatase-1 (SHIP) influences signals downstream of cytokine/chemokine receptors that play a role in megakaryocytopoiesis, including thrombopoietin, stromal-cell-derived-Factor-1/CXCL-12 and interleukin-3. We hypothesize that SHIP might control megakaryocytopoiesis through effects on proliferation of megakaryocyte progenitors (MKP) and megakaryocytes (MK).</p></sec><sec><title>Methodology and Principal Findings</title><p>Herein, we report the megakaryocytic phenotype and MK functional assays of hematopoietic organs of two strains of SHIP deficient mice with deletion of the SHIP promoter/first exon or the inositol phosphatase domain. Both SHIP deficient strains exhibit a profound increase in MKP numbers in bone marrow (BM), spleen and blood as analyzed by flow cytometry (Lin<sup>&#x02212;</sup>c-Kit<sup>&#x0002b;</sup>CD41<sup>&#x0002b;</sup>) and functional assays (CFU-MK). SHIP deficient MKP display increased phosphorylation of Signal Transducers and Activators of Transcription 3 (STAT-3), protein kinase B (PKB/AKT) and extracellular signal-regulated kinases (ERKs). Despite increased MKP content, total body number of mature MK (Lin<sup>&#x02212;</sup>c-kit<sup>&#x02212;</sup>CD41<sup>&#x0002b;</sup>) are not significantly changed as SHIP deficient BM contains reduced MK while spleen MK numbers are increased. Reduction of CXCR-4 expression in SHIP deficient MK may influence MK localization to the spleen instead of the BM. Endomitosis, process involved in MK maturation, was preserved in SHIP deficient MK. Circulating platelets and red blood cells are also reduced in SHIP deficient mice.</p></sec><sec><title>Conclusions/Significance</title><p>SHIP may play an important role in regulation of essential signaling pathways that control early megakaryocytopoiesis <italic>in vivo</italic>.</p></sec></abstract><counts><page-count count="8"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>SH2-containing-5&#x02032;inositol phosphatase-1 (SHIP) can catalyze the removal of the 5&#x02032; phosphate group from phosphatidylinositol-3,4,5-phosphate (PIP3) and inositol-1,3,4,5&#x02013;tetrakisphosphate (IP4) <xref ref-type="bibr" rid="pone.0003565-Damen1">&#x0005b;1&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003565-Kavanaugh1">&#x0005b;2&#x0005d;</xref>. In this manner, SHIP can prevent the recruitment of pleckstrin homology containing proteins to the plasma membrane or prevent calcium uptake and thus regulate survival, proliferation and activation of hematopoietic cells <xref ref-type="bibr" rid="pone.0003565-Helgason1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003565-Liu1">&#x0005b;4&#x0005d;</xref>. SHIP deficiency has profound functional and pathological consequences as SHIP mutant mice suffer from osteoporosis <xref ref-type="bibr" rid="pone.0003565-Takeshita1">&#x0005b;5&#x0005d;</xref>, and a myeloproliferative disorder that leads to lung consolidation <xref ref-type="bibr" rid="pone.0003565-Helgason2">&#x0005b;6&#x0005d;</xref>. Analysis of SHIP mutant mice has demonstrated a pivotal role for SHIP <italic>in vivo</italic> in regulating the homeostasis of various cell types including tissue macrophages, osteoclasts, myeloid, natural killer (NK) and hematopoietic stem cells (HSC) <xref ref-type="bibr" rid="pone.0003565-Liu1">&#x0005b;4&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0003565-Wang1">&#x0005b;7&#x0005d;</xref>. We have shown that despite expansion of the HSC compartment, SHIP deficient mice have reduced long-term engraftment capacity and have an altered homing capacity due to reductions in key chemotaxis and adhesion receptors <xref ref-type="bibr" rid="pone.0003565-Desponts1">&#x0005b;8&#x0005d;</xref>. Furthermore, SHIP deficient mice have a promiscuous NK cell repertoire that permits engraftment of completely mismatched bone marrow (BM) without graft-versus-host disease <xref ref-type="bibr" rid="pone.0003565-Wang1">&#x0005b;7&#x0005d;</xref>.</p><p>SHIP is known to influence signaling pathways downstream of receptors for chemokines and cytokines involved in megakaryocytopoiesis and thrombopoiesis, such as thrombopoietin (TPO) <xref ref-type="bibr" rid="pone.0003565-Drachman1">&#x0005b;9&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0003565-Lok2">&#x0005b;12&#x0005d;</xref>, Stromal-cell-derived-Factor 1 (SDF-1/CXCL-12), <xref ref-type="bibr" rid="pone.0003565-Chernock1">&#x0005b;13&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0003565-Wang2">&#x0005b;16&#x0005d;</xref> and interleukin (IL)-3 <xref ref-type="bibr" rid="pone.0003565-Liu2">&#x0005b;17&#x0005d;</xref>. TPO influences megakaryocyte (MK) development by controlling proliferation, differentiation, survival and endoduplication <xref ref-type="bibr" rid="pone.0003565-Kaushansky2">&#x0005b;18&#x0005d;</xref>. Circulating platelets sequester free TPO, and thereby limit megakaryocytopoiesis during steady-state hematopoiesis <xref ref-type="bibr" rid="pone.0003565-Burstein1">&#x0005b;19&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0003565-Kuter1">&#x0005b;23&#x0005d;</xref>. Upon binding of TPO to its receptor, <italic>c-mpl</italic>, phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) pathways are activated promoting cycling and survival of MK <xref ref-type="bibr" rid="pone.0003565-Drachman1">&#x0005b;9&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003565-Drachman2">&#x0005b;24&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003565-Geddis1">&#x0005b;25&#x0005d;</xref>. TPO binding to <italic>c-mpl</italic> also leads to SHIP phosphorylation <xref ref-type="bibr" rid="pone.0003565-Drachman1">&#x0005b;9&#x0005d;</xref>, which may be a negative regulator of these signaling pathways. Furthermore, Lyn kinase deficient mice have an increased MK progenitor pool associated with a reduction of SHIP phosphorylation, implicating SHIP in MK development inhibition <xref ref-type="bibr" rid="pone.0003565-Lannutti1">&#x0005b;26&#x0005d;</xref>.</p><p>SDF-1/CXCL12 induces transendothelial MK migration and platelet production <italic>in vitro</italic> {Hamada, <italic>et al</italic> 1998, Wang, <italic>et al</italic> 1998} and increases platelets in NOD/SCID and Balb/c mice <xref ref-type="bibr" rid="pone.0003565-Hattori1">&#x0005b;15&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003565-Lane1">&#x0005b;27&#x0005d;</xref>. We have shown that SDF-1 enhances human thrombopoiesis in xenotransplanted NOD/SCID mice <xref ref-type="bibr" rid="pone.0003565-Perez1">&#x0005b;28&#x0005d;</xref>. SDF-1 and fibroblast growth factor-4 allow hematopoietic progenitors to relocate to a BM microenvironment that is permissive and instructive for MK maturation and thrombopoiesis <xref ref-type="bibr" rid="pone.0003565-Avecilla1">&#x0005b;29&#x0005d;</xref>. SHIP deficient myeloid progenitors exhibit enhanced chemotaxis towards SDF-1/CXCL-12, indicating that SHIP influences signaling downstream of its receptor, CXCR-4 <xref ref-type="bibr" rid="pone.0003565-Kim1">&#x0005b;30&#x0005d;</xref>. However, our recent demonstration that SHIP deficiency reduces both the surface density of CXCR-4 and homing of HSC indicates SHIP deficiency can also compromise CXCR-4 signaling <xref ref-type="bibr" rid="pone.0003565-Desponts1">&#x0005b;8&#x0005d;</xref>.</p><p>It has been reported that SHIP deficient BM have decreased number of colony-forming-unit megakaryocytes (CFU-Mk) <xref ref-type="bibr" rid="pone.0003565-Moody1">&#x0005b;31&#x0005d;</xref>, and SHIP has also been shown to regulate PIP3 levels after thrombin or collagen induced platelet activation <xref ref-type="bibr" rid="pone.0003565-Giuriato1">&#x0005b;32&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003565-Giuriato2">&#x0005b;33&#x0005d;</xref>. Based on the defined role for SHIP in signaling pathways for cytokine/chemokines that also regulate MK and platelet biology, we hypothesized that SHIP might be involved in the regulation of megakaryocytopoiesis and platelet production <italic>in vivo</italic>. Herein, we report that two strains of SHIP deficient mice exhibit increased numbers of megakaryocyte progenitors (MKP) in hematopoietic organs as determined by flow cytometry (Lin<sup>&#x02212;</sup>c-Kit<sup>&#x0002b;</sup>CD41<sup>&#x0002b;</sup>) and functional assays (colony forming unit (CFU)-MK). Despite the increase in MKP, mature MK (Lin<sup>&#x02212;</sup>c-Kit<sup>&#x02212;</sup>CD41<sup>&#x0002b;</sup>) numbers are not significantly changed since MK redistribute to other organs in the SHIP deficient animal. Moreover, MK endoduplication function is preserved in SHIP deficient MK, as well as circulating platelet numbers, which are not proportionally increased as would be expected. Interestingly, SHIP deficient MKP exhibit increased phosphorylation of Signal Transducers and Activators of Transcription 3 (STAT-3), protein kinase B (PKB/AKT) and extracellular signal-regulated kinases (ERKs). Furthermore, CXCR-4 surface expression is reduced on SHIP deficient MK as we previously showed for HSC <xref ref-type="bibr" rid="pone.0003565-Desponts1">&#x0005b;8&#x0005d;</xref> contributing, in part, to localization of MK progenitors to peripheral hematopoietic organs. These findings suggest that SHIP might be important for the control of early MK development.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>SHIP deficient bone marrow, spleen and blood contain increased numbers of functional MKP</title><p>Histological evaluation of Hematoxylin-Eosin stained spleens from two strains of SHIP deficient mice revealed that there is an impressive infiltrate of morphologically appearing MK. BM histopathology revealed that MK in SHIP deficient (SHIP<sup>&#x02212;/&#x02212;</sup>) BM are equally represented compared to wild type (WT) control. MK morphology in SHIP deficient mice showed that they are hypolobulated micro-MK when compared to WT BM which contained hyperlobulated MK (<xref ref-type="fig" rid="pone-0003565-g001">Figure 1A</xref>). Immuno-staining with anti-Glycoprotein IIB-IIIA (CD41a) antibody corroborated the MK lineage nature of the cells observed in spleen and BM (<xref ref-type="fig" rid="pone-0003565-g001">Figure 1B</xref>).</p><fig id="pone-0003565-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003565.g001</object-id><label>Figure 1</label><caption><title>MK morphology and Glycoprotein IIB-IIIa (CD41) immunostain in BM and spleen of SHIP deficient mice.</title><p>(A). Hematoxylin-Eosin staining of BM and spleen of SHIP<sup>&#x02212;/&#x02212;</sup> (&#x02212;/&#x02212;) and wild type (WT) littermate controls. Spleen of SHIP deficient mice is characterized by a massive infiltrate with morphologically appearing MK (left panel) compared to WT littermates (right panel). BM of SHIP<sup>&#x02212;/&#x02212;</sup> mice contained hypolobulated micro-MK compared to hyperlobulated MK in WT BM. Magnification: &#x000d7;60. Results are representative of those obtained in 3 animals per experimental group (B). Glycoprotein IIB-IIIA (CD41) immuno-histochemistry. Spleen of SHIP<sup>&#x02212;/&#x02212;</sup> mice contained a higher percentage of CD41<sup>&#x0002b;</sup> cells compared to WT spleen. Magnification: &#x000d7;40. BM of SHIP deficient mice contained comparable number of CD41<sup>&#x0002b;</sup> cells compared to WT. Magnification: &#x000d7;60.</p></caption><graphic xlink:href="pone.0003565.g001"/></fig><p>To further characterize the megakaryocytic compartment in SHIP deficient mice, we assessed the presence of early MKP, immuno-stained as Lin<sup>&#x02212;</sup>c-Kit<sup>&#x0002b;</sup>CD41<sup>&#x0002b;</sup>, and of more differentiated MK, identified as Lin<sup>&#x02212;</sup>c-Kit<sup>&#x02212;</sup> CD41<sup>&#x0002b;</sup> (<xref ref-type="fig" rid="pone-0003565-g002">Figure 2A</xref>) <xref ref-type="bibr" rid="pone.0003565-Hodohara1">&#x0005b;34&#x0005d;</xref>. The MKP (Lin<sup>&#x02212;</sup>c-Kit<sup>&#x0002b;</sup>CD41<sup>&#x0002b;</sup>) compartment in the BM, spleen and peripheral blood (PB) of both SHIP deficient mice (SHIP<sup>&#x02212;/&#x02212;</sup> and SHIP<sup>&#x00394;IP/&#x00394;IP</sup>) was increased as compared to WT mice (<xref ref-type="fig" rid="pone-0003565-g002">Figure 2B</xref>). In BM, there was a mean 18.1 fold and 50 fold increase in SHIP<sup>&#x02212;/&#x02212;</sup> and SHIP<sup>&#x00394;IP/&#x00394;IP</sup> as compared to their WT littermates, respectively. The absolute number of splenic MKP was increased by more than 30 fold in both strains of mice. SHIP<sup>&#x02212;/&#x02212;</sup> PB contained fewer MKP (3 to 5 MKP/&#x000b5;l), but MKP numbers were significantly higher in SHIP<sup>&#x00394;IP/&#x00394;IP</sup> mice compared to control mice (<xref ref-type="fig" rid="pone-0003565-g002">Figure 2B</xref>). We then combined the number of MKP present in the BM and spleen in SHIP deficient mice to establish the total MKP body number. In both mice strains (SHIP<sup>&#x02212;/&#x02212;</sup> and SHIP<sup>&#x00394;IP/&#x00394;IP</sup>), the total MKP pool was increased by a mean of 3.5 fold as compared to their respective WT littermates (<xref ref-type="fig" rid="pone-0003565-g002">Figure 2C</xref>).</p><fig id="pone-0003565-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003565.g002</object-id><label>Figure 2</label><caption><title>SHIP deficient mice have increased number of functional MKP in hematopoietic organs.</title><p>(A) BM, spleen, and PB MKP phenotype in SHIP<sup>&#x02212;/&#x02212;</sup> (&#x02212;/&#x02212;) and SHIP<sup>&#x00394;IP/&#x00394;IP</sup> (&#x00394;IP/&#x00394;IP) mice. Shown are representative flow cytometry dot plots of CD41 (<italic>x</italic>-axis) versus c-Kit (<italic>y</italic>-axis) after gating on live and Lin<sup>&#x02212;</sup> cells. MKP (Lin<sup>&#x02212;</sup>c-Kit<sup>&#x0002b;</sup>CD41<sup>&#x0002b;</sup>) are represented in the right upper quadrants and MK (Lin<sup>&#x02212;</sup>c-Kit<sup>&#x02212;</sup>CD41<sup>&#x0002b;</sup>) are represented in the right lower quadrants. Percentages for each population are indicated on each plot. (B) Represented are the mean&#x000b1;standard error mean (SEM) (n&#x0200a;&#x0003d;&#x0200a;4 for experimental groups WT C57Bl6 and SHIP<sup>&#x02212;/&#x02212;</sup>, while n&#x0200a;&#x0003d;&#x0200a;6 for experimental groups WT 129SvJ and SHIP<sup>&#x00394;IP/&#x00394;IP</sup>) of the absolute numbers of MKP in BM, spleen and PB of SHIP deficient mice (black columns) compared to respective WT littermates (gray columns). Mice strains specified in the graphs. (C) Represented is the mean&#x000b1;SEM (n&#x0200a;&#x0003d;&#x0200a;4 for experimental groups WT C57Bl6 and SHIP<sup>&#x02212;/&#x02212;</sup>, while n&#x0200a;&#x0003d;&#x0200a;6 for experimental groups WT 129SvJ and SHIP<sup>&#x00394;IP/&#x00394;IP</sup>) of total body MKP numbers determined as the calculated sum of MKP in one whole spleen plus MKP in one femur &#x000d7;16.6 (since one femur is estimated to contained 6&#x00025; the total marrow) <xref ref-type="bibr" rid="pone.0003565-Helgason1">&#x0005b;3&#x0005d;</xref>. (D) Represented is the mean&#x000b1;SEM of CFU-MK colonies in BM and spleen of SHIP<sup>&#x02212;/&#x02212;</sup> (n&#x0200a;&#x0003d;&#x0200a;7) and WT (n&#x0200a;&#x0003d;&#x0200a;7) littermates. Statistical analysis was established using the Mann-Whitney test. <italic>p</italic> values indicated on each graph.</p></caption><graphic xlink:href="pone.0003565.g002"/></fig><p>To further evaluate the functional capacity of MK precursors (MKP) in SHIP deficient hematopoietic organs, we determined CFU-MK activity in both the spleen and BM. We observed an increased CFU-MK content in SHIP deficient BM although the difference did not reach statistical significance (p&#x0003e;0.05). CFU-MK in SHIP deficient spleen were statistically significantly increased (p&#x0003c;0.05) compared to WT, corroborating flow cytometry findings (<xref ref-type="fig" rid="pone-0003565-g002">Figure 2D</xref>).</p></sec><sec id="s2b"><title>SHIP deficient MK are redistributed within hematopoietic organs</title><p>Despite an increase in total MKP numbers in both strains of SHIP deficient mice, BM MK content was decreased by a mean 2 fold in SHIP<sup>&#x02212;/&#x02212;</sup> and SHIP<sup>&#x00394;IP/&#x00394;IP</sup> while the absolute number of splenic MK was increased by a mean 10.9 fold in SHIP<sup>&#x02212;/&#x02212;</sup> spleen and an even more dramatic increase in SHIP<sup>&#x00394;IP/&#x00394;IP</sup> spleen. Furthermore, SHIP<sup>&#x02212;/&#x02212;</sup> PB showed a mean 7.7 fold increase in the absolute number of MK and the same trend was observed for SHIP<sup>&#x00394;IP/&#x00394;IP</sup> mice (<xref ref-type="fig" rid="pone-0003565-g003">Figure 3A</xref>). Nevertheless the total MK content in SHIP deficient mice was equivalent to WT littermates (<xref ref-type="fig" rid="pone-0003565-g003">Figure 3B</xref>). These observations suggest a shift in the site of megakaryocytopoiesis from the BM to the spleen. This is in agreement with other findings suggesting that the spleen of SHIP deficient mice becomes a site of intense extramedullar hematopoiesis <xref ref-type="bibr" rid="pone.0003565-Helgason1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003565-Helgason2">&#x0005b;6&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003565-Desponts1">&#x0005b;8&#x0005d;</xref>.</p><fig id="pone-0003565-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003565.g003</object-id><label>Figure 3</label><caption><title>SHIP deficient mice MK are redistributed within hematopoietic organs.</title><p>(A) Represented are the mean&#x000b1;SEM (n&#x0200a;&#x0003d;&#x0200a;4 for experimental groups WT C57Bl6 and SHIP<sup>&#x02212;/&#x02212;</sup>, while n&#x0200a;&#x0003d;&#x0200a;6 for experimental groups WT 129SvJ and SHIP<sup>&#x00394;IP/&#x00394;IP</sup>) of the absolute numbers of MK (Lin<sup>&#x02212;</sup>c-Kit<sup>&#x02212;</sup>CD41<sup>&#x0002b;</sup>) in BM, spleen and PB of SHIP deficient mice (black columns) compared to respective WT littermates (gray columns). Mice strains specified in the graphs. (B) Represented is the mean&#x000b1;SEM (n&#x0200a;&#x0003d;&#x0200a;4 for experimental groups WT C57Bl6 and SHIP<sup>&#x02212;/&#x02212;</sup>, while n&#x0200a;&#x0003d;&#x0200a;6 for experimental groups WT 129SvJ and SHIP<sup>&#x00394;IP/&#x00394;IP</sup>) of total body numbers of MK determined as the calculated sum of MK numbers in one whole spleen plus MK in one femur &#x000d7;16.6 (since one femur is estimated to contain 6&#x00025; of the total marrow) <xref ref-type="bibr" rid="pone.0003565-Helgason1">&#x0005b;3&#x0005d;</xref>. Significance was established using the Mann-Whitney test. <italic>p</italic> values indicated on each graph.</p></caption><graphic xlink:href="pone.0003565.g003"/></fig></sec><sec id="s2c"><title>SHIP deficient MK have reduced CXCR-4 surface expression</title><p>We identified that SHIP<sup>&#x02212;/&#x02212;</sup> HSC have fewer CXCR-4 receptors indicating that SHIP deficiency may also compromise SDF-1/CXCR-4 signaling in hematopoietic cells <xref ref-type="bibr" rid="pone.0003565-Desponts1">&#x0005b;8&#x0005d;</xref>. CXCR-4<sup>&#x0002b;</sup> cells mobilize towards an increased SDF-1 gradient determining their localization to the BM, the organ with highest SDF-1 concentration <xref ref-type="bibr" rid="pone.0003565-Hamada1">&#x0005b;14&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003565-Wang2">&#x0005b;16&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003565-Avecilla1">&#x0005b;29&#x0005d;</xref>. In order to address whether increased MK content in spleen is due to migration between organs we evaluated CXCR-4 expression in SHIP deficient MK. Flow cytometry analysis revealed that BM SHIP<sup>&#x02212;/&#x02212;</sup> MK exhibit a significant reduction in CXCR-4 expression as compared to WT MK (<xref ref-type="fig" rid="pone-0003565-g004">Figure 4A</xref>). The mean fluorescence intensity (MFI) for CXCR-4 on SHIP<sup>&#x02212;/&#x02212;</sup> MK was 1.29&#x000b1;0.06 &#x000d7;10<sup>4</sup>, while it was 3.12&#x000b1;0.45 &#x000d7;10<sup>4</sup> in WT littermates (<xref ref-type="fig" rid="pone-0003565-g004">Figure 4B</xref>). This mean 2.4 fold decrease in CXCR-4 expression in BM SHIP<sup>&#x02212;/&#x02212;</sup> MK may influence the ability of these cells to home and/or be retained in the BM.</p><fig id="pone-0003565-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003565.g004</object-id><label>Figure 4</label><caption><title>SHIP<sup>&#x02212;/&#x02212;</sup> MK have lowered CXCR-4 receptor expression.</title><p>(A) Histogram representing the level of CXCR-4 receptor expression on SHIP<sup>&#x02212;/&#x02212;</sup> (black line) and WT (gray line) Lin<sup>&#x02212;</sup>c-kit<sup>&#x02212;</sup>CD41<sup>&#x0002b;</sup> cells in BM. Isotype antibody control indicated in the histogram. (B) Represented is the mean&#x000b1;SEM of the mean fluorescence (MFI) intensity of CXCR-4 expression on SHIP<sup>&#x02212;/&#x02212;</sup> (&#x02212;/&#x02212;) (n&#x0200a;&#x0003d;&#x0200a;4) and WT (n&#x0200a;&#x0003d;&#x0200a;4) Lin<sup>&#x02212;</sup>c-kit<sup>&#x02212;</sup>CD41<sup>&#x0002b;</sup> in BM. Significance was established using the Mann-Whitney test. <italic>p</italic> values indicated in each graph.</p></caption><graphic xlink:href="pone.0003565.g004"/></fig></sec><sec id="s2d"><title>Phosphorylation of signaling proteins in SHIP deficient MKP</title><p>SHIP is known to negatively influence signaling proteins downstream of cytokine receptors involved in MK differentiation and/or development; therefore we assessed phosphorylation of the major signaling proteins in SHIP deficient MKP. We observed as expected that SHIP<sup>&#x00394;IP/&#x00394;IP</sup> BM MKP exhibit enhanced STAT-3, Erk1/2 and Akt phosphorylation (P) when compared to WT as determined by flow cytometry (<xref ref-type="fig" rid="pone-0003565-g005">Figure 5A</xref>). SHIP<sup>&#x00394;IP/&#x00394;IP</sup> MKP exhibited an average 1.5 fold increased in MFI values for P-STAT3, P-Erk, and P-Akt (<xref ref-type="fig" rid="pone-0003565-g005">Figure 5B</xref>). Interestingly, there were no significant differences in the percentage of cells containing P-Stat3, P-Erk1/2 and P-Akt (data not shown) between SHIP<sup>&#x00394;IP/&#x00394;IP</sup> MKP and WT MKP, but rather a difference in the level of phosphorylation on a per cell basis.</p><fig id="pone-0003565-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003565.g005</object-id><label>Figure 5</label><caption><title>Increased phosphorylation of signaling proteins in SHIP<sup>&#x02212;/&#x02212;</sup> MKP in BM.</title><p>(A) Histogram representing the level of phospho-STAT3, phospho-Erk1/2 and phospho-Akt in Lin<sup>&#x02212;</sup>c-kit<sup>&#x0002b;</sup>CD41<sup>&#x0002b;</sup> BM cells isolated from SHIP<sup>&#x02212;/&#x02212;</sup> (black line) and WT (gray line) mice. Isotype antibody control indicated on the histogram. (B) Represented is the mean&#x000b1;SEM of the mean fluorescence (MFI) intensity of phospho-STAT3, phospho-Erk1/2 and phospho-Akt on SHIP<sup>&#x02212;/&#x02212;</sup> (&#x02212;/&#x02212;) (n&#x0200a;&#x0003d;&#x0200a;4) and WT (n&#x0200a;&#x0003d;&#x0200a;4) Lin<sup>&#x02212;</sup>c-kit<sup>&#x0002b;</sup>CD41<sup>&#x0002b;</sup> in BM. Significance was established using the Mann-Whitney test. <italic>p</italic> values indicated on each graph.</p></caption><graphic xlink:href="pone.0003565.g005"/></fig></sec><sec id="s2e"><title>SHIP deficient MK precursors preserve endomitosis function</title><p>Megakaryocytic precursors, unlike other cells, continue to synthesize DNA during differentiation. We next evaluated the ploidy distribution of SHIP<sup>&#x02212;/&#x02212;</sup> Lin<sup>&#x02212;</sup>CD41<sup>&#x0002b;</sup> selected cells that morphologically appeared to have fewer nuclei lobules (micro-MK) compared to hyperlobulated MK in WT BM as shown in <xref ref-type="fig" rid="pone-0003565-g001">Figure 1</xref>. DNA content of Lin<sup>&#x02212;</sup>CD41<sup>&#x0002b;</sup> cells was determined by flow cytometry on BM cells and splenocytes from SHIP<sup>&#x02212;/&#x02212;</sup> and WT mice, after enriching for CD41<sup>&#x0002b;</sup> cells and staining with propidium iodide (<xref ref-type="fig" rid="pone-0003565-g006">Figure 6A</xref>). Ploidy distribution in SHIP deficient mice was similar to wild type littermates (p&#x0003e;0.05), thus, having a comparable ability to mature properly as endomitosis is an obligatory step towards differentiation (<xref ref-type="fig" rid="pone-0003565-g006">Figure 6B</xref>).</p><fig id="pone-0003565-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003565.g006</object-id><label>Figure 6</label><caption><title>SHIP deficient MK precursors preserve endomitotic function.</title><p>BM and splenocytes from SHIP<sup>&#x02212;/&#x02212;</sup> and WT mice were enriched for CD41<sup>&#x0002b;</sup> on AutoMACS, stained with Lin-panel and CD41-biotin/SA-APC, fixed/permeated and stained with PI in the presence of RNase. (A) Representative density plots of ploidy distribution of megakaryocytic cells. Lin<sup>&#x02212;</sup>CD41<sup>&#x0002b;</sup> cells were first selected by gating forward and side scatter by area and width. Propidium iodide (<italic>x</italic> axis) versus forward side scatter (<italic>y</italic> axis) density plots were then generated to assess ploidy distribution in BM (top panels) and spleen (bottom panels) of SHIP<sup>&#x02212;/&#x02212;</sup> and WT mice. (B) Represented is the mean&#x000b1;SEM (n&#x0200a;&#x0003d;&#x0200a;4 for each experimental group) percentage of BM (top) and spleen (bottom) Lin<sup>&#x02212;</sup>CD41<sup>&#x0002b;</sup> cells in different ploidy stages from 2N to 32 N. Statistical analysis was done using the Mann-Whitney test. <italic>p</italic> values indicated on each graph.</p></caption><graphic xlink:href="pone.0003565.g006"/></fig></sec><sec id="s2f"><title>SHIP deficient mice have diminished circulating platelets and red blood cells</title><p>Since MK numbers are not increased in SHIP deficient mice despite the increased MKP pool, we next evaluated whether terminal MK differentiation into circulating platelets was preserved in these mice. Analysis of SHIP<sup>&#x02212;/&#x02212;</sup> and SHIP<sup>&#x00394;IP/&#x00394;IP</sup> PB by hematolizer revealed that these mice have a statistically significant reduction in their platelet numbers as compared to WT littermates (<xref ref-type="table" rid="pone-0003565-t001">Table 1</xref>). Furthermore, both strains of SHIP mutant mice have a significantly lower hematocrit percentage compared to WT littermates (<xref ref-type="table" rid="pone-0003565-t001">Table 1</xref>). It remains to be determined whether thrombocytopenia could be related to hypersplenism due to significant increased spleen size in SHIP deficient mice <xref ref-type="bibr" rid="pone.0003565-Helgason1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003565-Helgason2">&#x0005b;6&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003565-Desponts1">&#x0005b;8&#x0005d;</xref>.</p><table-wrap id="pone-0003565-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0003565.t001</object-id><label>Table 1</label><caption><title>Platelet and Hematocrit counts in SHIP-deficient mice.</title></caption><graphic id="pone-0003565-t001-1" xlink:href="pone.0003565.t001"/><table frame="hsides" rules="groups" alternate-form-of="pone-0003565-t001-1"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">Mice genotype</td><td align="left" rowspan="1" colspan="1">Platelet levels (#&#x000d7;10<sup>3</sup>/&#x000b5;l)</td><td align="left" rowspan="1" colspan="1">Hematocrit (&#x00025;)</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">SHIP<sup>&#x02212;/&#x02212;</sup> (n&#x0200a;&#x0003d;&#x0200a;6)</td><td align="left" rowspan="1" colspan="1">672.8&#x000b1;43.4<xref ref-type="table-fn" rid="nt102">&#x02020;</xref></td><td align="left" rowspan="1" colspan="1">42.5&#x000b1;1.4<xref ref-type="table-fn" rid="nt101">&#x0002a;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">SHIP<sup>&#x0002b;/&#x02212;</sup> (n&#x0200a;&#x0003d;&#x0200a;10)</td><td align="left" rowspan="1" colspan="1">848.9&#x000b1;35.7</td><td align="left" rowspan="1" colspan="1">45.2&#x000b1;0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">SHIP<sup>&#x0002b;/&#x0002b;</sup> (C57Bl6) (n&#x0200a;&#x0003d;&#x0200a;12)</td><td align="left" rowspan="1" colspan="1">803.7&#x000b1;31.5</td><td align="left" rowspan="1" colspan="1">46.6&#x000b1;0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">SHIP<sup>&#x00394;IP/&#x00394;IP</sup>(n&#x0200a;&#x0003d;&#x0200a;5)</td><td align="left" rowspan="1" colspan="1">455.4&#x000b1;81.1<xref ref-type="table-fn" rid="nt102">&#x02020;</xref></td><td align="left" rowspan="1" colspan="1">43.1&#x000b1;1.4<xref ref-type="table-fn" rid="nt102">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">SHIP<sup>&#x0002b;/&#x00394;IP</sup>(n&#x0200a;&#x0003d;&#x0200a;9)</td><td align="left" rowspan="1" colspan="1">652.3&#x000b1;28.0</td><td align="left" rowspan="1" colspan="1">46.8&#x000b1;0.5</td></tr><tr><td align="left" rowspan="1" colspan="1">SHIP<sup>&#x0002b;/&#x0002b;</sup>(129SvJ)(n&#x0200a;&#x0003d;&#x0200a;8)</td><td align="left" rowspan="1" colspan="1">647.9&#x000b1;28.0</td><td align="left" rowspan="1" colspan="1">47.0&#x000b1;0.6</td></tr></tbody></table><table-wrap-foot><fn id="nt101"><label>&#x0002a;</label><p>p&#x0003e;0.05 compared to their respective WT littermates.</p></fn><fn id="nt102"><label>&#x02020;</label><p>p&#x0003c;0.05 compared to their respective WT and SHIP heterozygous littermates.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s3"><title>Discussion</title><p>Using two strains of SHIP mutant mice with either deletion of the SHIP promoter/first exon (SHIP<sup>&#x02212;/&#x02212;</sup> mice) <xref ref-type="bibr" rid="pone.0003565-Wang1">&#x0005b;7&#x0005d;</xref> or the inositol phosphatase domain (SHIP<sup>&#x00394;IP/&#x00394;IP</sup>) <xref ref-type="bibr" rid="pone.0003565-Ono1">&#x0005b;35&#x0005d;</xref>, we report that ablation of SHIP results in an increased number of early megakaryocyte progenitors (Lin<sup>&#x02212;</sup>c-Kit<sup>&#x0002b;</sup>CD41<sup>&#x0002b;</sup>-MKP) in BM, spleen and PB of SHIP deficient mice as determined by flow cytometry and functional assay (CFU-MK). SHIP deficient MKP showed enhanced activation of STAT-3, AKT and ERK</p><p>SHIP deficient MKP altered phenotype could be related to unknown intrinsic mechanism and/or related to the cytokine profile of these mice. SHIP deficient mice are characterized by an inflammatory state associated with increased numbers of inflammatory cells <xref ref-type="bibr" rid="pone.0003565-Helgason2">&#x0005b;6&#x0005d;</xref>. SHIP deficient mice have been shown to have increased levels of IL-6 <xref ref-type="bibr" rid="pone.0003565-Takeshita1">&#x0005b;5&#x0005d;</xref> and TPO (Kerr et al, unpublished results) that could contribute to enhance megakaryocytopoiesis in these mice.</p><p>In contrast, the total number of differentiated megakaryocytes (Lin<sup>&#x02212;</sup>c-Kit<sup>&#x02212;</sup>CD41<sup>&#x0002b;</sup> MK) was unaltered in SHIP deficient mice. Furthermore, DNA endoduplication was not affected in SHIP deficient megakaryocytes. However, MK were predominately localized to the spleen and blood with decreased numbers in the BM. We postulate that aberrant MK localization could be related to extramedullary hematopoiesis of SHIP deficient mice since they have increased HSC content in the spleen <xref ref-type="bibr" rid="pone.0003565-Helgason1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0003565-Desponts1">&#x0005b;8&#x0005d;</xref> and/or related to MK migration. We have shown that MK (Lin<sup>&#x02212;</sup>c-Kit<sup>&#x02212;</sup>CD41<sup>&#x0002b;</sup>) have decreased CXCR-4 expression that could potentially contribute to their spleen localization instead of retention to the BM space given the higher SDF-1 concentration in this organ.</p><p>SHIP deficient mice also exhibit decreased number of platelets as previously shown <xref ref-type="bibr" rid="pone.0003565-Moody1">&#x0005b;31&#x0005d;</xref>. In addition, both strains of SHIP deficient mice exhibit a decrease in hematocrit percentages as previously shown in F6-7 SHIP<sup>&#x02212;/&#x02212;</sup> mice <xref ref-type="bibr" rid="pone.0003565-Moody1">&#x0005b;31&#x0005d;</xref>. This finding suggests that SHIP may be involved in modulating signaling pathways of early precursors involved in both the MK and erythroid lineages.</p><p>In conclusion, our results suggest that SHIP negatively controls pathways promoting early megakaryocytopoiesis without compromising mechanism underlying megakaryocytic endomitosis. Increased MKP compartment without a proportional increase of more differentiated MK and platelets in SHIP deficient mice may support the hypothesis that early megakaryocytopoiesis and late megakaryocyte development and platelet shedding may be regulated by distinct mechanisms.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Mice strains</title><p>SHIP<sup>&#x02212;/&#x02212;</sup> mice (F9 or F10&#x000d7;C57BL6/J) produced in our laboratory have a deletion of the SHIP promoter and first exon <xref ref-type="bibr" rid="pone.0003565-Wang1">&#x0005b;7&#x0005d;</xref>. A second SHIP deficient mouse model was also analyzed, SHIP<sup>&#x00394;IP/&#x00394;IP</sup> (129SvJ) <xref ref-type="bibr" rid="pone.0003565-Karlsson1">&#x0005b;36&#x0005d;</xref>, in which the inositol phosphatase domain is deleted (kindly provided by Dr. Jeffrey Ravetch, Rockefeller University, NY, USA). All studies described herein were conducted on six to eight week-old adult mice. Experiments were performed in compliance with institutional guidelines of the University of South Florida.</p></sec><sec id="s4b"><title>Cell isolation</title><p>Isolation of BM cells and splenocytes was as described previously <xref ref-type="bibr" rid="pone.0003565-Desponts1">&#x0005b;8&#x0005d;</xref>. Following red blood cell (RBC) lysis, the cells were resuspended in staining media <xref ref-type="bibr" rid="pone.0003565-Desponts1">&#x0005b;8&#x0005d;</xref>. PB was obtained from the retro-orbital sinus, sub-mandibular, or heart. For MKP analysis of PB, RBC were lysed twice in 1&#x000d7; RBC lysis buffer (eBioscience). Cells were then resuspended for antibody staining.</p></sec><sec id="s4c"><title>Flow cytometry analysis and antibodies</title><p>Staining of MKP and MK was performed as per Hodohara et al <xref ref-type="bibr" rid="pone.0003565-Hodohara1">&#x0005b;34&#x0005d;</xref>. All antibodies were from BD Biosciences except when mentioned. The cells were treated with anti-CD16/CD32 (2.4G2) to block Fc receptors and then stained with a Lin panel-PE, CD41-FITC (MWReg30), and c-Kit-APC (2B8). The Lin- panel was CD3&#x003b5; (17A2), CD4 (GK1.5), CD8&#x003b1; (53-6.7), B220 (RA3-6B2), Gr-1 (RB6-8C5), Mac-1 (M1/70) (Caltag, Burlingame, CA) and Ter119 (TER-119). Dead cells were excluded using 7-AAD (BD Biosciences). Data was acquired on a FACS Calibur using the FACS Quest software and analysis was done using FlowJo 4.5. For the CXCR-4 analysis, the antibodies mentioned above were used to define the MKP population. CXCR-4 antibody (2B11/CXCR-4) conjugated to biotin was added to the stain, which was revealed using a streptavidin-PeCy7 antibody. For this stain, dead cells were excluded using DAPI (Sigma-Aldrich) and data was acquired on a FACS LSR (BD Dickenson).</p></sec><sec id="s4d"><title>Platelet analysis</title><p>Blood was collected by heart puncture using a 25 gauge needle with an EDTA coated 1 ml syringe, or by sub-mandibular bleed. For each method the blood was collected directly into microtainer K<sub>2</sub>EDTA tubes (BD, Franklin, NJ, USA). 200 &#x000b5;l of blood (either diluted 1&#x02236;4 or whole blood) was then analyzed on the CellDyn 3700 hematology analyzer using the Veterinary Package Software (Abbott Diagnostic, Dallas, Texas USA), with a ratio to default corresponding to the mice strain studied.</p></sec><sec id="s4e"><title>Histopathology</title><p>Bone and spleen were fixed in 10&#x00025; buffered paraformaldehyde. Bones were first decalcified using Routine Acid Decalcification (RDO; Apex engineering Products, Plainfield, IL, USA), followed by sectioning. The spleen and bone sections were then stained with Hematoxylin-Eosin after being deparaffinized with xylene or stained with Glycoprotein IIB-IIIA (CD41) antibody. Briefly, slides were stained using the modified Meyer's Hematoxylin and Eosin phloxine B solution (Fisher Scientific, Suwanee, GA, USA) according to a modified Armed Forces Institute of Pathology (AFIP) protocol. Cells were visualized on a Leica DM LB microscope. Pictures were taken using a RTcolor Spot camera (Diagnostic Instrument Inc) with Spot Advance v3.0 software.</p></sec><sec id="s4f"><title>Ploidy assay</title><p>BM cells were isolated from hind/fore limb and vertebral column. Briefly, cells were incubated on ice with CD41-biotin antibody (Serotec, Raleigh, NC, USA) and then with anti-biotin beads (Miltenyi Biotec) at 4&#x000b0;C. CD41<sup>&#x0002b;</sup> cells were then selected using the autoMACS (Miltenyi Biotec). Collected CD41<sup>&#x0002b;</sup> cells were stained with Lin panel-FITC as mentioned above and with streptavidin-APC (BD Biosciences). The cells were fixed in 1&#x00025; formaldehyde (Sigma-Aldrich) for 15 minutes on ice and then incubated overnight in a 70&#x00025; ethanol solution at &#x02212;20&#x000b0;C. The day after, the cells were washed carefully of any residual ethanol with PBS and incubated for at least 3 hours in a propidium iodine (PI) solution composed of 50 &#x000b5;g/ml PI, 0.1&#x00025; Triton X-100, 2.5 U/ml RNase in PBS without Ca or MG (all from Sigma-Aldrich except for the PBS which was from Gibco BRL/Invitrogen).</p></sec><sec id="s4g"><title>CFU-MK assay</title><p>Hundred thousand 10<sup>5</sup> whole BM cells were assessed for megakaryocyte progenitor activity in a CFU-Mk assay, MegaCult-C (Stem cell Technologies, Vancouver, CA) per the manufacturer's instructions.</p></sec><sec id="s4h"><title>Phosphorylation analysis of signaling proteins</title><p>Phospho-flow analysis was performed on BM cells isolated from 129SvJ WT and SHIP<sup>&#x00394;IP/&#x00394;IP</sup>. Cells were isolated on ice, after red blood cell lysis, cells were stained for Lin<sup>&#x02212;</sup>c-kit<sup>&#x0002b;</sup>CD41<sup>&#x0002b;</sup> using the same antibody clones than mentioned above, except for c-kit which was conjugated to PeCy7 instead of APC. Cells were then directly fixed with Fix buffer (BD Biosciences) for 10 minutes at 37&#x000b0;C and washed with Perm/Wash buffer I (BD Biosciences). After centrifugation, the cells were resuspended in Perm/Wash buffer I. The appropriate phospho-antibody was added to the cells, and incubated at RT for 30 minutes. The cells were then washed twice in Perm/wash buffer I and stored in that same buffer on ice until the time of acquisition The phospho-antibodies were from BD Biosciences, anti-phospho-Stat3Y705 (clone 4/P-Stat3), anti-phospho ERK1/2 T202/T204 (clone 20a), anti phosphor Akt S473) (clone F29-763). The analysis was carried on a BD LSR II (BD Biosciences).</p></sec><sec id="s4i"><title>Statistical analysis</title><p>Statistical analysis for each experiment consisted of the Mann-Whitney test performed using the Prism software. For each experiment, the number of individual mice analyzed is indicated as &#x0201c;n&#x0201d; in the figure legends. All mice were analyzed individually (i.e. the cells from different animals were not pooled together for these experiments).</p></sec></sec></body><back><ack><p>We thank Davina Mulchan B.S., Kim H.T. Paraiso M.Sc., and Sarah May B.S. for genotyping of the mice. We thank the U.S.F. Pathology Core Facility and the Animal Core Facilities and Jodi L. Kroeger from the Flow Cytometry Core at the H. Lee Moffitt Comprehensive Cancer Center for their technical assistance in this study. We also thank John Ninos MD for discussion and Daniela Wood B.S. for technical assistance.</p></ack><ref-list><title>References</title><ref id="pone.0003565-Damen1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Damen</surname><given-names>JE</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Rosten</surname><given-names>P</given-names></name><name><surname>Humphries</surname><given-names>RK</given-names></name><name><surname>Jefferson</surname><given-names>AB</given-names></name><etal/></person-group><year>1996</year><article-title>The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase.</article-title><source>Proc Natl Acad Sci U S A</source><volume>93</volume><fpage>1689</fpage><lpage>1693</lpage><pub-id pub-id-type="pmid">8643691</pub-id></citation></ref><ref id="pone.0003565-Kavanaugh1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kavanaugh</surname><given-names>WM</given-names></name><name><surname>Pot</surname><given-names>DA</given-names></name><name><surname>Chin</surname><given-names>SM</given-names></name><name><surname>Deuter-Reinhard</surname><given-names>M</given-names></name><name><surname>Jefferson</surname><given-names>AB</given-names></name><etal/></person-group><year>1996</year><article-title>Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2.</article-title><source>Curr Biol</source><volume>6</volume><fpage>438</fpage><lpage>445</lpage><pub-id pub-id-type="pmid">8723348</pub-id></citation></ref><ref id="pone.0003565-Helgason1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Helgason</surname><given-names>CD</given-names></name><name><surname>Antonchuk</surname><given-names>J</given-names></name><name><surname>Bodner</surname><given-names>C</given-names></name><name><surname>Humphries</surname><given-names>RK</given-names></name></person-group><year>2003</year><article-title>Homeostasis and regeneration of the hematopoietic stem cell pool are altered in SHIP-deficient mice.</article-title><source>Blood</source><volume>102</volume><fpage>3541</fpage><lpage>3547</lpage><pub-id pub-id-type="pmid">12855581</pub-id></citation></ref><ref id="pone.0003565-Liu1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Kozieradzki</surname><given-names>I</given-names></name><name><surname>Wakeham</surname><given-names>A</given-names></name><name><surname>Itie</surname><given-names>A</given-names></name><etal/></person-group><year>1999</year><article-title>SHIP is a negative regulator of growth factor receptor-mediated PKB/Akt activation and myeloid cell survival.</article-title><source>Genes Dev</source><volume>13</volume><fpage>786</fpage><lpage>791</lpage><pub-id pub-id-type="pmid">10197978</pub-id></citation></ref><ref id="pone.0003565-Takeshita1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takeshita</surname><given-names>S</given-names></name><name><surname>Namba</surname><given-names>N</given-names></name><name><surname>Zhao</surname><given-names>JJ</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Genant</surname><given-names>HK</given-names></name><etal/></person-group><year>2002</year><article-title>SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts.</article-title><source>Nat Med</source><volume>8</volume><fpage>943</fpage><lpage>949</lpage><pub-id pub-id-type="pmid">12161749</pub-id></citation></ref><ref id="pone.0003565-Helgason2"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Helgason</surname><given-names>CD</given-names></name><name><surname>Damen</surname><given-names>JE</given-names></name><name><surname>Rosten</surname><given-names>P</given-names></name><name><surname>Grewal</surname><given-names>R</given-names></name><name><surname>Sorensen</surname><given-names>P</given-names></name><etal/></person-group><year>1998</year><article-title>Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span.</article-title><source>Genes Dev</source><volume>12</volume><fpage>1610</fpage><lpage>1620</lpage><pub-id pub-id-type="pmid">9620849</pub-id></citation></ref><ref id="pone.0003565-Wang1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JW</given-names></name><name><surname>Howson</surname><given-names>JM</given-names></name><name><surname>Ghansah</surname><given-names>T</given-names></name><name><surname>Desponts</surname><given-names>C</given-names></name><name><surname>Ninos</surname><given-names>JM</given-names></name><etal/></person-group><year>2002</year><article-title>Influence of SHIP on the NK repertoire and allogeneic bone marrow transplantation.</article-title><source>Science</source><volume>295</volume><fpage>2094</fpage><lpage>2097</lpage><pub-id pub-id-type="pmid">11896280</pub-id></citation></ref><ref id="pone.0003565-Desponts1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Desponts</surname><given-names>C</given-names></name><name><surname>Hazen</surname><given-names>AL</given-names></name><name><surname>Paraiso</surname><given-names>KH</given-names></name><name><surname>Kerr</surname><given-names>WG</given-names></name></person-group><year>2006</year><article-title>SHIP deficiency enhances HSC proliferation and survival but compromises homing and repopulation.</article-title><source>Blood</source><volume>107</volume><fpage>4338</fpage><lpage>4345</lpage><pub-id pub-id-type="pmid">16467196</pub-id></citation></ref><ref id="pone.0003565-Drachman1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Drachman</surname><given-names>JG</given-names></name><name><surname>Kaushansky</surname><given-names>K</given-names></name></person-group><year>1997</year><article-title>Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain.</article-title><source>Proc Natl Acad Sci U S A</source><volume>94</volume><fpage>2350</fpage><lpage>2355</lpage><pub-id pub-id-type="pmid">9122198</pub-id></citation></ref><ref id="pone.0003565-Kaushansky1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaushansky</surname><given-names>K</given-names></name></person-group><year>1994</year><article-title>The mpl ligand: molecular and cellular biology of the critical regulator of megakaryocyte development.</article-title><source>Stem Cells</source><volume>12</volume><issue>Suppl 1</issue><fpage>91</fpage><lpage>96</lpage><comment>discussion 96&#x02013;97</comment><pub-id pub-id-type="pmid">7696972</pub-id></citation></ref><ref id="pone.0003565-Lok1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lok</surname><given-names>S</given-names></name><name><surname>Foster</surname><given-names>DC</given-names></name></person-group><year>1994</year><article-title>The structure, biology and potential therapeutic applications of recombinant thrombopoietin.</article-title><source>Stem Cells</source><volume>12</volume><fpage>586</fpage><lpage>598</lpage><pub-id pub-id-type="pmid">7881359</pub-id></citation></ref><ref id="pone.0003565-Lok2"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lok</surname><given-names>S</given-names></name><name><surname>Kaushansky</surname><given-names>K</given-names></name><name><surname>Holly</surname><given-names>RD</given-names></name><name><surname>Kuijper</surname><given-names>JL</given-names></name><name><surname>Lofton-Day</surname><given-names>CE</given-names></name><etal/></person-group><year>1994</year><article-title>Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo.</article-title><source>Nature</source><volume>369</volume><fpage>565</fpage><lpage>568</lpage><pub-id pub-id-type="pmid">8202158</pub-id></citation></ref><ref id="pone.0003565-Chernock1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chernock</surname><given-names>RD</given-names></name><name><surname>Cherla</surname><given-names>RP</given-names></name><name><surname>Ganju</surname><given-names>RK</given-names></name></person-group><year>2001</year><article-title>SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways.</article-title><source>Blood</source><volume>97</volume><fpage>608</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">11157475</pub-id></citation></ref><ref id="pone.0003565-Hamada1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamada</surname><given-names>T</given-names></name><name><surname>Mohle</surname><given-names>R</given-names></name><name><surname>Hesselgesser</surname><given-names>J</given-names></name><name><surname>Hoxie</surname><given-names>J</given-names></name><name><surname>Nachman</surname><given-names>RL</given-names></name><etal/></person-group><year>1998</year><article-title>Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation.</article-title><source>J Exp Med</source><volume>188</volume><fpage>539</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">9687531</pub-id></citation></ref><ref id="pone.0003565-Hattori1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hattori</surname><given-names>K</given-names></name><name><surname>Heissig</surname><given-names>B</given-names></name><name><surname>Tashiro</surname><given-names>K</given-names></name><name><surname>Honjo</surname><given-names>T</given-names></name><name><surname>Tateno</surname><given-names>M</given-names></name><etal/></person-group><year>2001</year><article-title>Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells.</article-title><source>Blood</source><volume>97</volume><fpage>3354</fpage><lpage>3360</lpage><pub-id pub-id-type="pmid">11369624</pub-id></citation></ref><ref id="pone.0003565-Wang2"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JF</given-names></name><name><surname>Liu</surname><given-names>ZY</given-names></name><name><surname>Groopman</surname><given-names>JE</given-names></name></person-group><year>1998</year><article-title>The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion.</article-title><source>Blood</source><volume>92</volume><fpage>756</fpage><lpage>764</lpage><pub-id pub-id-type="pmid">9680341</pub-id></citation></ref><ref id="pone.0003565-Liu2"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Damen</surname><given-names>JE</given-names></name><name><surname>Cutler</surname><given-names>RL</given-names></name><name><surname>Krystal</surname><given-names>G</given-names></name></person-group><year>1994</year><article-title>Multiple cytokines stimulate the binding of a common 145-kilodalton protein to Shc at the Grb2 recognition site of Shc.</article-title><source>Mol Cell Biol</source><volume>14</volume><fpage>6926</fpage><lpage>6935</lpage><pub-id pub-id-type="pmid">7523859</pub-id></citation></ref><ref id="pone.0003565-Kaushansky2"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaushansky</surname><given-names>K</given-names></name><name><surname>Lok</surname><given-names>S</given-names></name><name><surname>Holly</surname><given-names>RD</given-names></name><name><surname>Broudy</surname><given-names>VC</given-names></name><name><surname>Lin</surname><given-names>N</given-names></name><etal/></person-group><year>1994</year><article-title>Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin.</article-title><source>Nature</source><volume>369</volume><fpage>568</fpage><lpage>571</lpage><pub-id pub-id-type="pmid">8202159</pub-id></citation></ref><ref id="pone.0003565-Burstein1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burstein</surname><given-names>SA</given-names></name><name><surname>Adamson</surname><given-names>JW</given-names></name><name><surname>Erb</surname><given-names>SK</given-names></name><name><surname>Harker</surname><given-names>LA</given-names></name></person-group><year>1981</year><article-title>Megakaryocytopoiesis in the mouse: response to varying platelet demand.</article-title><source>J Cell Physiol</source><volume>109</volume><fpage>333</fpage><lpage>341</lpage><pub-id pub-id-type="pmid">7298733</pub-id></citation></ref><ref id="pone.0003565-Burstein2"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burstein</surname><given-names>SA</given-names></name><name><surname>Harker</surname><given-names>LA</given-names></name></person-group><year>1983</year><article-title>Control of platelet production.</article-title><source>Clin Haematol</source><volume>12</volume><fpage>3</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">6340885</pub-id></citation></ref><ref id="pone.0003565-Harker1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harker</surname><given-names>LA</given-names></name><name><surname>Finch</surname><given-names>CA</given-names></name></person-group><year>1969</year><article-title>Thrombokinetics in man.</article-title><source>J Clin Invest</source><volume>48</volume><fpage>963</fpage><lpage>974</lpage><pub-id pub-id-type="pmid">5814231</pub-id></citation></ref><ref id="pone.0003565-Kaushansky3"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kaushansky</surname><given-names>K</given-names></name></person-group><year>1998</year><article-title>Thrombopoietin.</article-title><source>N Engl J Med</source><volume>339</volume><fpage>746</fpage><lpage>754</lpage><pub-id pub-id-type="pmid">9731092</pub-id></citation></ref><ref id="pone.0003565-Kuter1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuter</surname><given-names>DJ</given-names></name></person-group><year>1996</year><article-title>The physiology of platelet production.</article-title><source>Stem Cells</source><volume>14</volume><issue>Suppl 1</issue><fpage>88</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">11012207</pub-id></citation></ref><ref id="pone.0003565-Drachman2"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Drachman</surname><given-names>JG</given-names></name><name><surname>Sabath</surname><given-names>DF</given-names></name><name><surname>Fox</surname><given-names>NE</given-names></name><name><surname>Kaushansky</surname><given-names>K</given-names></name></person-group><year>1997</year><article-title>Thrombopoietin signal transduction in purified murine megakaryocytes.</article-title><source>Blood</source><volume>89</volume><fpage>483</fpage><lpage>492</lpage><pub-id pub-id-type="pmid">9002950</pub-id></citation></ref><ref id="pone.0003565-Geddis1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geddis</surname><given-names>AE</given-names></name><name><surname>Fox</surname><given-names>NE</given-names></name><name><surname>Kaushansky</surname><given-names>K</given-names></name></person-group><year>2001</year><article-title>Phosphatidylinositol 3-kinase is necessary but not sufficient for thrombopoietin-induced proliferation in engineered Mpl-bearing cell lines as well as in primary megakaryocytic progenitors.</article-title><source>J Biol Chem</source><volume>276</volume><fpage>34473</fpage><lpage>34479</lpage><pub-id pub-id-type="pmid">11418622</pub-id></citation></ref><ref id="pone.0003565-Lannutti1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lannutti</surname><given-names>BJ</given-names></name><name><surname>Minear</surname><given-names>J</given-names></name><name><surname>Blake</surname><given-names>N</given-names></name><name><surname>Drachman</surname><given-names>JG</given-names></name></person-group><year>2006</year><article-title>Increased megakaryocytopoiesis in Lyn-deficient mice.</article-title><source>Oncogene</source><volume>25</volume><fpage>3316</fpage><lpage>3324</lpage><pub-id pub-id-type="pmid">16418722</pub-id></citation></ref><ref id="pone.0003565-Lane1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname><given-names>WJ</given-names></name><name><surname>Dias</surname><given-names>S</given-names></name><name><surname>Hattori</surname><given-names>K</given-names></name><name><surname>Heissig</surname><given-names>B</given-names></name><name><surname>Choy</surname><given-names>M</given-names></name><etal/></person-group><year>2000</year><article-title>Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases.</article-title><source>Blood</source><volume>96</volume><fpage>4152</fpage><lpage>4159</lpage><pub-id pub-id-type="pmid">11110686</pub-id></citation></ref><ref id="pone.0003565-Perez1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>LE</given-names></name><name><surname>Alpdogan</surname><given-names>O</given-names></name><name><surname>Shieh</surname><given-names>JH</given-names></name><name><surname>Wong</surname><given-names>D</given-names></name><name><surname>Merzouk</surname><given-names>A</given-names></name><etal/></person-group><year>2004</year><article-title>Increased plasma levels of stromal-derived factor-1 (SDF-1/CXCL12) enhance human thrombopoiesis and mobilize human colony-forming cells (CFC) in NOD/SCID mice.</article-title><source>Exp Hematol</source><volume>32</volume><fpage>300</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">15003316</pub-id></citation></ref><ref id="pone.0003565-Avecilla1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Avecilla</surname><given-names>ST</given-names></name><name><surname>Hattori</surname><given-names>K</given-names></name><name><surname>Heissig</surname><given-names>B</given-names></name><name><surname>Tejada</surname><given-names>R</given-names></name><name><surname>Liao</surname><given-names>F</given-names></name><etal/></person-group><year>2004</year><article-title>Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis.</article-title><source>Nat Med</source><volume>10</volume><fpage>64</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">14702636</pub-id></citation></ref><ref id="pone.0003565-Kim1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CH</given-names></name><name><surname>Hangoc</surname><given-names>G</given-names></name><name><surname>Cooper</surname><given-names>S</given-names></name><name><surname>Helgason</surname><given-names>CD</given-names></name><name><surname>Yew</surname><given-names>S</given-names></name><etal/></person-group><year>1999</year><article-title>Altered responsiveness to chemokines due to targeted disruption of SHIP.</article-title><source>J Clin Invest</source><volume>104</volume><fpage>1751</fpage><lpage>1759</lpage><pub-id pub-id-type="pmid">10606629</pub-id></citation></ref><ref id="pone.0003565-Moody1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moody</surname><given-names>JL</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Helgason</surname><given-names>CD</given-names></name><name><surname>Jirik</surname><given-names>FR</given-names></name></person-group><year>2004</year><article-title>Anemia, thrombocytopenia, leukocytosis, extramedullary hematopoiesis, and impaired progenitor function in Pten&#x0002b;/&#x02212; SHIP&#x02212;/&#x02212;mice: a novel model of myelodysplasia.</article-title><source>Blood</source></citation></ref><ref id="pone.0003565-Giuriato1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giuriato</surname><given-names>S</given-names></name><name><surname>Payrastre</surname><given-names>B</given-names></name><name><surname>Drayer</surname><given-names>AL</given-names></name><name><surname>Plantavid</surname><given-names>M</given-names></name><name><surname>Woscholski</surname><given-names>R</given-names></name><etal/></person-group><year>1997</year><article-title>Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human blood platelets.</article-title><source>J Biol Chem</source><volume>272</volume><fpage>26857</fpage><lpage>26863</lpage><pub-id pub-id-type="pmid">9341117</pub-id></citation></ref><ref id="pone.0003565-Giuriato2"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giuriato</surname><given-names>S</given-names></name><name><surname>Pesesse</surname><given-names>X</given-names></name><name><surname>Bodin</surname><given-names>S</given-names></name><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Viala</surname><given-names>C</given-names></name><etal/></person-group><year>2003</year><article-title>SH2-containing inositol 5-phosphatases 1 and 2 in blood platelets: their interactions and roles in the control of phosphatidylinositol 3,4,5-trisphosphate levels.</article-title><source>Biochem J</source><volume>376</volume><fpage>199</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">12885297</pub-id></citation></ref><ref id="pone.0003565-Hodohara1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hodohara</surname><given-names>K</given-names></name><name><surname>Fujii</surname><given-names>N</given-names></name><name><surname>Yamamoto</surname><given-names>N</given-names></name><name><surname>Kaushansky</surname><given-names>K</given-names></name></person-group><year>2000</year><article-title>Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK).</article-title><source>Blood</source><volume>95</volume><fpage>769</fpage><lpage>775</lpage><pub-id pub-id-type="pmid">10648384</pub-id></citation></ref><ref id="pone.0003565-Ono1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ono</surname><given-names>M</given-names></name><name><surname>Okada</surname><given-names>H</given-names></name><name><surname>Bolland</surname><given-names>S</given-names></name><name><surname>Yanagi</surname><given-names>S</given-names></name><name><surname>Kurosaki</surname><given-names>T</given-names></name><etal/></person-group><year>1997</year><article-title>Deletion of SHIP or SHP-1 reveals two distinct pathways for inhibitory signaling.</article-title><source>Cell</source><volume>90</volume><fpage>293</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">9244303</pub-id></citation></ref><ref id="pone.0003565-Karlsson1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karlsson</surname><given-names>MC</given-names></name><name><surname>Guinamard</surname><given-names>R</given-names></name><name><surname>Bolland</surname><given-names>S</given-names></name><name><surname>Sankala</surname><given-names>M</given-names></name><name><surname>Steinman</surname><given-names>RM</given-names></name><etal/></person-group><year>2003</year><article-title>Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone.</article-title><source>J Exp Med</source><volume>198</volume><fpage>333</fpage><lpage>340</lpage><pub-id pub-id-type="pmid">12874264</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This work was supported in part by grants from the NIH (RO1 DK54767, RO1 HL72523) and academic development funds from Moffitt Cancer Center. LEP is supported by NHLBI K08 Career Development Award (1 K08 HL77662-01A1). WGK is The Newman Scholar of the Leukemia and Lymphoma Society of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article> 